MAPK8 and Alzheimer disease: Compared to ERK and JNK, p38 displayed a more robust activation in the AD fibroblasts, peaking at 2–5 min with 25 nM and 5–10 min with 250 nM BK stimulation and subsiding by 30 min (Figure 5A–C).